Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers

Carol A. Derby, Anne Lamont Hume, Janice B. McPhillips, Marilyn McFarland Barbour, Richard A. Carleton

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to investigate whether selection of healthy women for postmenopausal estrogen therapy may confound observational studies of estrogen use and cardiovascular disease risk. STUDY DESIGN: Data were obtained from baseline (1981 to 1984) and follow-up (1990 to 1992) health surveys of two cohorts randomly selected from communities in southeastern New England. At follow-up postmenopausal women ≥ 40 years old were categorized as current users (n = 70) or nonusers (n = 772) of noncontraceptive estrogens. Users and nonusers were compared on both prior characteristics from the baseline surveys and current characteristics measured at follow-up by use of analysis of covariance. RESULTS: Prior levels of total and high- density lipoprotein cholesterol, body mass index, and blood pressure were similar for estrogen users and nonusers. Estrogen users were less likely to have smoked and more likely to have had their cholesterol checked and to exercise regularly. These differences were more pronounced for current characteristics than for baseline characteristics. CONCLUSIONS: Selection of healthy women for treatment may not fully explain the apparent protective effect of estrogen replacement on cardiovascular risk. However, more healthy profiles among estrogen users may inflate the apparent benefit of treatment in observational studies.

Original languageEnglish (US)
Pages (from-to)544-550
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume173
Issue number2
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Estrogen Replacement Therapy
Estrogens
Health
Observational Studies
New England
Health Surveys
HDL Cholesterol
Body Mass Index
Cardiovascular Diseases
Therapeutics
Cholesterol
Exercise
Blood Pressure

Keywords

  • Estrogen replacement therapy
  • hormones
  • menopause

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. / Derby, Carol A.; Hume, Anne Lamont; McPhillips, Janice B.; Barbour, Marilyn McFarland; Carleton, Richard A.

In: American Journal of Obstetrics and Gynecology, Vol. 173, No. 2, 1995, p. 544-550.

Research output: Contribution to journalArticle

Derby, Carol A. ; Hume, Anne Lamont ; McPhillips, Janice B. ; Barbour, Marilyn McFarland ; Carleton, Richard A. / Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. In: American Journal of Obstetrics and Gynecology. 1995 ; Vol. 173, No. 2. pp. 544-550.
@article{d9452ffd929f49d2aca3046da6f30b7b,
title = "Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers",
abstract = "OBJECTIVE: Our purpose was to investigate whether selection of healthy women for postmenopausal estrogen therapy may confound observational studies of estrogen use and cardiovascular disease risk. STUDY DESIGN: Data were obtained from baseline (1981 to 1984) and follow-up (1990 to 1992) health surveys of two cohorts randomly selected from communities in southeastern New England. At follow-up postmenopausal women ≥ 40 years old were categorized as current users (n = 70) or nonusers (n = 772) of noncontraceptive estrogens. Users and nonusers were compared on both prior characteristics from the baseline surveys and current characteristics measured at follow-up by use of analysis of covariance. RESULTS: Prior levels of total and high- density lipoprotein cholesterol, body mass index, and blood pressure were similar for estrogen users and nonusers. Estrogen users were less likely to have smoked and more likely to have had their cholesterol checked and to exercise regularly. These differences were more pronounced for current characteristics than for baseline characteristics. CONCLUSIONS: Selection of healthy women for treatment may not fully explain the apparent protective effect of estrogen replacement on cardiovascular risk. However, more healthy profiles among estrogen users may inflate the apparent benefit of treatment in observational studies.",
keywords = "Estrogen replacement therapy, hormones, menopause",
author = "Derby, {Carol A.} and Hume, {Anne Lamont} and McPhillips, {Janice B.} and Barbour, {Marilyn McFarland} and Carleton, {Richard A.}",
year = "1995",
doi = "10.1016/0002-9378(95)90280-5",
language = "English (US)",
volume = "173",
pages = "544--550",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers

AU - Derby, Carol A.

AU - Hume, Anne Lamont

AU - McPhillips, Janice B.

AU - Barbour, Marilyn McFarland

AU - Carleton, Richard A.

PY - 1995

Y1 - 1995

N2 - OBJECTIVE: Our purpose was to investigate whether selection of healthy women for postmenopausal estrogen therapy may confound observational studies of estrogen use and cardiovascular disease risk. STUDY DESIGN: Data were obtained from baseline (1981 to 1984) and follow-up (1990 to 1992) health surveys of two cohorts randomly selected from communities in southeastern New England. At follow-up postmenopausal women ≥ 40 years old were categorized as current users (n = 70) or nonusers (n = 772) of noncontraceptive estrogens. Users and nonusers were compared on both prior characteristics from the baseline surveys and current characteristics measured at follow-up by use of analysis of covariance. RESULTS: Prior levels of total and high- density lipoprotein cholesterol, body mass index, and blood pressure were similar for estrogen users and nonusers. Estrogen users were less likely to have smoked and more likely to have had their cholesterol checked and to exercise regularly. These differences were more pronounced for current characteristics than for baseline characteristics. CONCLUSIONS: Selection of healthy women for treatment may not fully explain the apparent protective effect of estrogen replacement on cardiovascular risk. However, more healthy profiles among estrogen users may inflate the apparent benefit of treatment in observational studies.

AB - OBJECTIVE: Our purpose was to investigate whether selection of healthy women for postmenopausal estrogen therapy may confound observational studies of estrogen use and cardiovascular disease risk. STUDY DESIGN: Data were obtained from baseline (1981 to 1984) and follow-up (1990 to 1992) health surveys of two cohorts randomly selected from communities in southeastern New England. At follow-up postmenopausal women ≥ 40 years old were categorized as current users (n = 70) or nonusers (n = 772) of noncontraceptive estrogens. Users and nonusers were compared on both prior characteristics from the baseline surveys and current characteristics measured at follow-up by use of analysis of covariance. RESULTS: Prior levels of total and high- density lipoprotein cholesterol, body mass index, and blood pressure were similar for estrogen users and nonusers. Estrogen users were less likely to have smoked and more likely to have had their cholesterol checked and to exercise regularly. These differences were more pronounced for current characteristics than for baseline characteristics. CONCLUSIONS: Selection of healthy women for treatment may not fully explain the apparent protective effect of estrogen replacement on cardiovascular risk. However, more healthy profiles among estrogen users may inflate the apparent benefit of treatment in observational studies.

KW - Estrogen replacement therapy

KW - hormones

KW - menopause

UR - http://www.scopus.com/inward/record.url?scp=0029154369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029154369&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(95)90280-5

DO - 10.1016/0002-9378(95)90280-5

M3 - Article

C2 - 7645633

AN - SCOPUS:0029154369

VL - 173

SP - 544

EP - 550

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -